Open Clinical Investigation to Evaluate the Effectiveness & Safety of a

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The primary endpoint is the change of the itching score after 3 days of the product use in comparison to the basal value.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Chickenpox

Clinical Trial Details

NCT number	NCT05732337
Study type	Interventional
Source	Karo Pharma AB
Contact
Status	Completed
Phase	N/A
Start date	January 30, 2023
Completion date	July 5, 2023

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01887496` - Varicella-related Hospitalizations in Turkey	N/A
	Completed	`NCT02570126` - A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.	Phase 3
	Completed	`NCT00326183` - Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)	Phase 4
	Completed	`NCT02452229` - Review of Human Herpes Viruses in Burns	N/A
	Completed	`NCT01815073` - Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine	Phase 4
	Completed	`NCT01817270` - Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine	Phase 4
	Active, not recruiting	`NCT01982409` - Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children	Phase 4
	Completed	`NCT00921999` - Immune Response to Varicella-Zoster Vaccination and Infection	N/A
	Completed	`NCT00098046` - Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection	Phase 3
	Completed	`NCT01684072` - Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin	Phase 4
	Completed	`NCT00156559` - MMR and Varicella Vaccine in Premature Infants	Phase 4
	Active, not recruiting	`NCT05084508` - A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age	Phase 2
	Completed	`NCT04384016` - Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old	Phase 4
	Withdrawn	`NCT00001054` - The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children	Phase 1
	Completed	`NCT00000953` - Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients	Phase 2
	Completed	`NCT00002358` - A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV	Phase 3
	Completed	`NCT00002315` - A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems	Phase 3
	Completed	`NCT00001125` - Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox	Phase 1